Introgen Therapeutics, Inc. develops gene therapy products for the treatment of cancer. The Company's lead product candidate combines the p53 gene, a tumor suppressor gene, with a gene delivery system that it has developed and tested. Introgen is developing cancer therapies which are based on restoring normal cellular function through gene therapy.
301 Congress Avenue
Austin, TX 78701